Future DNA Sequencing Techniques

DNA sequencing has undergone radical advances since the first Sanger sequencing method was introduced in 1977. Sanger sequencing made use of randomly added chain-terminating deoxynucleotides during DNA synthesis to generate DNA chains of lengths differing by one base pair. Those were then separated on a polyacrylamide gel and “read” left to right like a book. Today, there is a wide array of improved methods with rapid and precise results.

DNA sequence. Image Credit: Gio.tto / Shutterstock
DNA sequence. Image Credit: Gio.tto / Shutterstock

From Sanger Method to Single Molecule Sequencing

In the late 1990s and 2000s, the Human Genome Project drove improvements on the aforementioned Sanger method that included whole genome shotgun sequencing and next-generation sequencing methods. By breaking up large sequences of DNA and sequencing them simultaneously in a massively parallel fashion, data could be generated faster. With improving computer technology, the sequence could then be reassembled and whole genomes began to be decoded.

Companies like Solexa and Life Technologies improved on those methods yet again, creating next generation sequencing technologies. In next generation sequencing, DNA template fragments are attached to solid surfaces like glass slides or microbeads for more automated, high throughput handling. Some chemical innovations have been added in second generation sequencing. These methods were developed and gained popularity in the 2000s.

Even newer methods are now on the horizon. Single molecule sequencing (SMS) is an approach that bypasses amplification by PCR, a crucial step in all next generation technologies. PCR amplification multiplies the original template DNA fragment by hundreds or thousands of times so that it can be visualized by optical detection methods.

SMS methods interrogate a single DNA molecule, overcoming problems and biases introduced by the PCR process. The potential advantages of SMS over next-generation sequencing include faster turnaround time, longer read lengths, higher accuracy, less starting material, and lower cost. It is estimated that with SMS, a whole genome might be sequenced for as little as $100.

Helicos Genetic Analysis

The Helicos Genetic Analysis Platform sequences individual DNA molecules bonded to a flat surface as they are extended. Fluorescently labeled nucleotide analogs, called Virtual Terminator nucleotides. This technology still requires a pause after each round of extension to read the sequence, but it eliminates the PCR step required for next-generation technologies like Illumina and Roche 454.

The raw error rates on sequencing an individual DNA strand are more than 5 percent. However, when sequencing is carried out in a highly parallel manner, the consensus finished sequence accuracy is over 99 percent. This method can also be used to sequence RNA directly, by substituting reverse transcriptase for DNA polymerase. Helicos Genetic Analysis was used to sequence the genome of one of its co-founders, Dr. Stephen Quake, for under $50,000 in 2009. However, Helicos subsequently filed for Chapter 11 bankruptcy in 2012.

Helicos High Speed Gene Sequencing

Single Molecule Real Time Sequencing

Pacific Biosciences developed the Single Molecule Real Time (SMRT) Sequencing method, which is based on directly observing synthesis of a single strand of DNA. SMRT sequencing makes use of a nanometer-scale chamber to isolate a single DNA strand and DNA polymerase. The DNA polymerase molecule is anchored and then flooded with fluorescently labeled nucleotides.

The nucleotides can be detected as they diffuse down to the bound DNA strand and are recognized and incorporated by DNA polymerase. The diffusion and extension process happens in milliseconds, which means that DNA polymerase is added several bases per second. Because the fluorescent dye is attached to the nucleotide through a phosphate chain, it disconnects from the nucleotide during the DNA polymerase reaction, freeing itself from the growing DNA chain.

An important advantage of SMS technologies is that they sequence the molecule continuously, rather than pausing to read after each round of base extension. Also, the method has the propensity to generate longer sequence reads when compared to other platforms on the market today.

Single Molecule Real Time Sequencing - Pacific Biosciences

Further Reading

Last Updated: Jul 19, 2023

Dr. Catherine Shaffer

Written by

Dr. Catherine Shaffer

Catherine Shaffer is a freelance science and health writer from Michigan. She has written for a wide variety of trade and consumer publications on life sciences topics, particularly in the area of drug discovery and development. She holds a Ph.D. in Biological Chemistry and began her career as a laboratory researcher before transitioning to science writing. She also writes and publishes fiction, and in her free time enjoys yoga, biking, and taking care of her pets.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Shaffer, Catherine. (2023, July 19). Future DNA Sequencing Techniques. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/life-sciences/Future-DNA-Sequencing-Techniques.aspx.

  • MLA

    Shaffer, Catherine. "Future DNA Sequencing Techniques". News-Medical. 21 November 2024. <https://www.news-medical.net/life-sciences/Future-DNA-Sequencing-Techniques.aspx>.

  • Chicago

    Shaffer, Catherine. "Future DNA Sequencing Techniques". News-Medical. https://www.news-medical.net/life-sciences/Future-DNA-Sequencing-Techniques.aspx. (accessed November 21, 2024).

  • Harvard

    Shaffer, Catherine. 2023. Future DNA Sequencing Techniques. News-Medical, viewed 21 November 2024, https://www.news-medical.net/life-sciences/Future-DNA-Sequencing-Techniques.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-based liquid biopsy technology promises early detection of cancer recurrence